Effect of QVA149 on Exercise Tolerance in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Status:
Completed
Trial end date:
2011-11-01
Target enrollment:
Participant gender:
Summary
This study assessed the effect of once-daily indacaterol and glycopyrronium bromide (QVA149)
on exercise endurance in patients with moderate to severe Chronic Obstructive Pulmonary
Disease (COPD).